Tips, insights, and expert advice to help you manage brain and eye disease.
Our tools will help you understand and manage symptoms, treatment, and prevention of these diseases.
Learn more about the biological hallmarks of Alzheimer’s disease.
Discover the intricate role of tau, a small but crucial protein in the brain, and its connection to Alzheimer's disease.
Is it an infection, a toxic medication reaction, the effects of head injury, or something different? Learn about medical disorders that can mimic dementia and lead to misdiagnosis.
This article explores what Medicare covers, with a special note about long-term care and assisted living.
Doctors who prescribe Leqembi, a new FDA-approved Alzheimer’s disease drug, are required to enroll their patients in a registry to obtain Medicare insurance coverage. Here are six facts to know about patient registries, including how your privacy is protected.
Learn helpful caregiver tips for the holiday season.
Leqembi, an amyloid-clearing drug that's received full approval from the FDA, is offering renewed hope to people with early signs of dementia. Here’s what to know about it.
New research has shed light on the connection between ADHD and Alzheimer’s, including a first-of-its-kind study that suggests people who had ADHD as children may be more likely to develop Alzheimer’s as adults.
Some medications can cause memory loss, confusion, or other side effects similar to dementia symptoms. See a list of drugs that may lead to misdiagnosis.
Researchers, including BrightFocus grantees, have been examining how modifiable lifestyle interventions such as intermittent fasting, the “fasting-mimicking” diet (FMD), ketone supplementation, and other targeted diet changes can help people delay Alzheimer’s disease, improve cognition, and live longer.